Director, Global Market Access Strategy – Oncology (Remote)
IlluminaFull Time
Expert & Leadership (9+ years)
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With our purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives.
We are seeking a strategic and hands-on Head, Market Access to lead the development and execution of the U.S. market access strategy for Orca-T and future pipeline products. This individual will be a key member of the Commercial Leadership Team and will play a mission-critical role in shaping how patients, providers, and payers access and afford our therapies. This Leader will lead a high-impact team responsible for Field Market Access and U.S. Value, Access & Pricing Strategy.
Develops and commercializes cell therapies
Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.